VIVRE-COVID-19.fr

Study that helps to provide data to guide public action, in particular through the action of the Ministry of Health in the digital management of the COVID-19 crisis


Description of the Study:

  • Title: VIVRE-COVID19.fr 
  • Principal investigator: Jean-Pierre Thierry, Guillaume Desjeux, Laurent Chiche and François Montestruc.
  • Centers of Implementation: Promoted by France Assos Santé and supported by the Health Data Hub.
  • Study Population: Study intended for:
    – Residents of France.
    – Beneficiaries of Assurance Maladie.
    – Senior (≥ 18 years old).
    – With a physician-diagnosed chronic condition or disability (self-reported); or no condition and no disability (control population) or being a caregiver.
    – With a valid e-mail address, cell phone number and Internet connection.
  • Study Type: Epidemiological study.
  • Methods: When participating in the study, an initial questionnaire is filled in and every month the participant receives an email and an SMS from VIVRE-COVID19.fr to inform him/her that a new questionnaire is available. The questionnaire is automatically adapted to each person’s situation (age, active or retired, pathologies, disability, etc.).

Objectives of the Study:

Principal Objective: To measure over two years (May 2020 to May 2022) the feelings of the French population during this health crisis.

Secondary Objectives:
(1) To make known the problems related to the participant’s situation or pathology.
(2) To enlighten decision-makers on the issue of the long-term psychological impact of this pandemic on French society, and on the chronically ill and disabled population and their environment.
(3) To make the voice of the patient or caregiver known, both by the public and by decision-makers.

More about this Study:

Scientific Context: The coronavirus has suddenly entered our lives changing the way we live, work, communicate, consume … and take care of ourselves; an even more acute reality for the chronically ill who are also the most exposed.

Kwcdlbal
Logo



Other Epidemiological Studies:

Effectiveness of vaccine combination

Científicos franceses demuestran que la vacunación primaria con dos vacunas diferentes sería más eficaz que la vacunación con dos vacunas idénticas.

The Social Perception Of COVID-19 Vaccines

This study conducted by the UOC aims to find out the opinion of the Spanish population and professional healthcare personnel on the COVID-19 vaccines.

CombivacS

Clinical trial designed to evaluate the safety and immunogenicity of a dose of Comirnaty vaccine (Pfizer) in people who have previously received a dose of Vaxcevria vaccine (AstraZeneca).

MOOD-COVID

MOOD-COVID aims to study the impact of the pandemic on the mental health of pregnant women, young mothers and their children.

Emotional State Of Adults In The Process Of Bereavement By COVID-19

This study aims to analyse the emotional and spiritual state of adults who have lost a loved one due to COVID-19.

E-speranza-COVID19 Project

This study aims to demonstrate efficacy of Montelukast for patients with persistent COVID-19 to help them improve their quality of life.

Early Corticosteroid Treatment for COVID-19

This study proposal aims to determine whether early corticosteroid treatment can reduce the need for oxygen therapy and post-COVID sequelae.

MINDCOVID: Mental Health in a Pandemic

This study aims to assess the mental health impact and needs associated with COVID-19 in Spain.

CIBERESUCI COVID

CIBERES UCI COVID is a fundamental study that will improve care of critical patients infected by COVID-19.

NAUTILUS Project

The NAUTILUS project aims to develop an artificial intelligence platform to identify, predict and intervene on persistent symptoms in people who have suffered from COVID-19.